Author : Dr.Pankaj Kumar Meena 1
Date of Publication :30th December 2020
Abstract: Diabetes Mellitus is a group of metabolic diseases characterized by hyperglycemia resulting in defects in insulin secretion, insulin action or both. Chronic stage of diabetes mellitus is associated with long term damage, dysfunction and failure of different vitals organs, especially, the eyes, kidneys, heart and blood vessels. Generally affect above 10% of the world population between 29 to 50 years aged persons. Glycated Hemoglobin (HbA1c) increased in Type 2 Diabetes Mellitus and also increased Glycation of protein including Hemoglobin which lead to the formation of Advaced Glycated End Products (AGE). Among several markers of inflammation, high sensitivity C- reactive protein (hsCRP) is found to be significantly higher in people with diabetes. hsCRP has emerged as the ‘golden marker for inflammation’. CRP (C-reactive protein) is a strong acute phase reactant that increases in inflammatory and infectious conditions. The present study for the study of High Sensitivity C-Reactive Protein with respect to Glycated Hemoglobin in chronic type 2 diabetes mellitus patients.
Reference :
-
- Aneesh T, Rao M Y. Serum magnesium in type-2 diabetic patients with microalbuminuria and overt proteinuria. IOSR-JDMS. 2016;15(1):30-35.
- Rafi M D. Textbook of Biochemistry for Medical Students. 2nd ed. Universities Press (India) Private Limited;2014:732-734
- Satyanarayana U, Chakrapani U. Biochemistry (with Clinical Concepts & Case Study). 4 th ed. Elsevier Books and Allied (P) Ltd;2013:679
- Gohel M G, Chacko A N. Serum GGT activity and hsCRP level in patients with type 2 diabetes mellitus with good and poor glycemic control:An evidence linking oxidative stress, inflammation and glycemic control. Journal of Diabetes and Metabolic Disorder. 2013;12:56.
- Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem. 1969; 6:24-30
- Nathan D M, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine R J. Translating the A1c asay into estimated average glucose values. Diabetes care. 2008;31:1473- 1478
- Rifai N, Warnick G R. Lipids, Lipoproteins, Apolipoproteins and Other Cardiovascular Risk Factors. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 4th ed. St. Louis Missouri:Elsevier Publication;2008:963
- Varma V, Varma M, Varma A, Kumar R, Bharosay A and Vyas S. Serum total salic acid and highly sensitive C-reactive protein: Prognostic markers for the Diabetic Nephropathy. J Lab Physicians. 2016;8(1):25-26.
- Mangili R. Microalbuminuria in diabetes. Clin Chem Lab Med. 1998;36:941-6.
- Gohel M G, Chacko A N. Serum GGT activity and hsCRP level in patients with type 2 diabetes mellitus with good and poor glycemic control:An evidence linking oxidative stress, inflammation and glycemic control. Journal of Diabetes and Metabolic Disorder. 2013;12:56.
- Amanullah S, Jarari A, Govindam M, Basha M I and Khatheeja S. Association of hs-CRP with Diabetic and Non-diabetic individuals. JJBS. 2010;3(1):7.
- Rajarajeswari D, Naidu JN and Sowjanya B. Association of Dyslipidemia and Inflammatory markers in Type 2 Diabetes Mellitus. International Journal of applied Biology and Pharmaceutical Technology. 2011; 2(3): 419-423.
- Tajiri Yuji, Kazuo Mimura and Fumio Umeda. High sensitivity C-Reactive protein in Japanese patients with Type 2 Diabetes. Obes Res. 2005; 13(10): 1810-1816.